Fluorescence Recovery after Photobleaching of Yellow Fluorescent Protein Tagged p62 in Aggresome-like Induced Structures
March 26th, 2019
16.5K views
We describe a comprehensive and practical protocol for fluorescence recovery after photobleaching experiments with live cells. Although the protocol was used to measure the mobility of yellow fluorescent protein-tagged p62 in aggresome-like induced structures, it can be applied to a variety of microscopy systems and fluorescent proteins.
Overview
This study presents a comprehensive and practical protocol for fluorescence recovery after photobleaching (FRAP) experiments aimed at assessing protein mobility in live cells. Utilizing yellow fluorescent protein-tagged p62 in induced aggresome-like structures, the protocol demonstrates versatility across various microscopy systems and fluorescent proteins.
Key Study Components
Research Area
- Cell biology
- Microscopy techniques
- Protein mobility studies
Background
- Existing FRAP protocols are often incomplete or complex.
- The technique allows quantification of protein diffusion within subcellular compartments.
- FRAP has implications in therapeutic and diagnostic research.
Methods Used
- Fluorescence recovery after photobleaching
- Mammalian cells (RAW264.7 macrophages)
- Microscopy with specific laser settings and acquisition parameters
Main Results
- The protocol allows researchers to effectively measure protein mobility.
- Insights gained can be applied across various biological fields.
- Information obtained aids in optimizing drug delivery systems.
Conclusions
- This study provides a viable framework for conducting FRAP experiments in live cells.
- The protocol enriches the understanding of diffusion phenomena relevant to cell and molecular biology.
Frequently Asked Questions
What is fluorescence recovery after photobleaching?
Fluorescence recovery after photobleaching (FRAP) is a technique used to measure the mobility of proteins within live cells by tracking the recovery of fluorescence in bleached areas.
Can this protocol be used for organisms other than mammalian cells?
Yes, while the protocol is designed for mammalian cells, the concepts can be adapted for use in plant cells, yeast, and bacteria.
What are the main applications of FRAP?
FRAP techniques are applied in various research areas, including drug delivery optimization, developmental biology, and neuroscience.
How does one ensure accurate FRAP measurements?
Performing pilot experiments to optimize conditions and ensuring correct image acquisition parameters are critical for accurate FRAP measurements.
What equipment is needed for FRAP experiments?
FRAP requires specific microscopy equipment equipped with lasers and appropriate software to acquire and analyze fluorescence data.
Is FRAP useful for understanding drug delivery systems?
Yes, FRAP can be instrumental in quantifying diffusion rates within drug delivery systems, which informs the optimization of drug structures and compositions.
Who demonstrated the FRAP procedure in this study?
The procedure was demonstrated by Maleen Cabe, a technician, and David Rademacher, the core imaging facility manager.
Executive Industry Relevance
Quantifying protein mobility in live cells enables mechanistic de-risking of therapeutic targets by revealing diffusion dynamics within subcellular structures. This FRAP protocol supports target validation in early discovery by providing quantitative, reproducible measurements of protein behavior in disease-relevant systems. The approach enhances predictive confidence in lead identification by linking molecular mobility to functional outcomes in aggresome-associated pathways.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Measures p62 mobility in aggresome-like induced structures to interrogate therapeutic hypotheses about protein aggregation and clearance pathways.
- Operational Value: Provides a standardized, step-by-step method for quantifying mobile and immobile fractions and halftime of recovery in live macrophages.
- Predictive Value: Enables biological de-risking of targets involved in aggresome formation by linking fluorescence recovery kinetics to functional protein dynamics.
Screening & Assay Development
- Assay Readiness: Prepares validated YFP-p62 transfected RAW264.7 macrophages for downstream screening by establishing baseline mobility metrics in ALIS.
- Quantitative Outputs: Generates mobile fraction (22%), immobile fraction (78%), and halftime of recovery (2.14 minutes) as measurable endpoints for assay standardization.
- Platform Reuse: Supports adaptation to other fluorescent tags and subcellular compartments for broad screening applications in drug discovery.
Translational & Preclinical Research
- Disease Relevance: Uses LPS-stimulated murine macrophages to model inflammatory conditions relevant to neurodegenerative and metabolic diseases.
- Translational Continuity: Connects early discovery measurements of p62 mobility to preclinical evaluation of autophagy and aggresome-targeting therapeutics.
- Risk-Adjusted Decisions: Informs go/no-go criteria by quantifying target engagement and mobility changes in response to pathway modulation.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead identification to preclinical assessment by providing quantitative mobility data that informs mechanistic understanding and compound effects.
- Discovery Biology: Supports hypothesis testing of p62 function in aggresome formation by measuring its diffusion dynamics in live cells under inflammatory stimulation.
- Screening: Enables assay readiness through standardized image acquisition, bleach parameters, and ROI definition for consistent protein mobility measurements.
- Analytics: Delivers curve-fitted exponential recovery data to derive mobile fraction, immobile fraction, and halftime as quantitative readouts for compound screening.
- Translational Research: Links ALIS-associated p62 mobility to preclinical models of proteinopathy where aggresome dynamics influence therapeutic response.
- Enterprise Reuse: Establishes a reusable FRAP workflow applicable across protein targets, cell types, and subcellular compartments for portfolio-wide target de-risking.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by quantifying protein mobility in disease-relevant subcellular structures.
- Operational Value: Ensures reproducibility through standardized laser settings, acquisition parameters, and drift correction protocols.
- Strategic Value: Improves go/no-go decisions by providing kinetic data on target behavior that reduces late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on mobility profiles linked to functional pathways in inflammation and protein homeostasis.
Implementation Considerations
- Requires expertise in live-cell imaging, confocal microscopy, and fluorescence quantification.
- Needs confocal laser scanning microscope with argon laser, 63x oil objective, and environmental control for live-cell imaging.
- Demands cross-team standardization of ROI selection, bleach parameters, and image analysis pipelines for reproducible results.
- Involves adaptation considerations for different fluorescent tags, cell types, and subcellular structures beyond YFP-p62 in ALIS.
- Includes practical limitations such as phototoxicity risks, bleed-through artifacts, and the need for pilot experiments to optimize acquisition frequency and bleach intensity.
Biopharma FAQs
Why does measuring mobile fraction matter for target validation in aggresome-associated pathways?
Measuring the mobile fraction of p62 in aggresome-like induced structures quantifies the proportion of protein capable of diffusion, which reflects its functional state in aggregation pathways. A low mobile fraction (22%) indicates high immobilization, suggesting stable aggregate formation relevant to target engagement in proteinopathy models. This metric helps de-risk targets by linking mobility changes to pathway modulation in early discovery.
How does isolating the bleach region within ALIS support independent variable control in discovery pipelines?
Isolating the bleach region within the aggresome-like induced structure ensures that fluorescence recovery measurements reflect p62 mobility specifically in the disease-relevant subcellular compartment. This spatial control eliminates confounding signals from diffuse cytoplasm or organelles, enabling accurate attribution of recovery kinetics to the target protein in its pathological context. Precise ROI definition supports reliable comparison across experimental conditions in screening workflows.
What quantitative dependent variable measurements enable hit selection in compound screening?
The normalized corrected bleach ROI values over time generate a recovery curve from which mobile fraction, immobile fraction, and halftime of recovery are derived as quantitative endpoints. These measurements allow ranking of compounds based on their ability to alter p62 dynamics in ALIS, with changes in halftime or mobile fraction indicating modulation of protein mobility. Exponential curve fitting provides standardized analytics for comparing conditions across plates and experiments.
Why do replication requirements across cells and structures matter for cross-functional collaboration?
Collecting FRAP data from 10 aggresome-like induced structures in 10 cells ensures sufficient statistical power to account for biological variability in protein mobility within heterogeneous populations. This replication standard supports data comparability between discovery biology, assay development, and preclinical teams by minimizing noise from single-cell anomalies. Consistent n-values enable reliable transfer of assays across sites and functional groups in industrial settings.
What statistical analysis capabilities are required before implementing this FRAP protocol in drug discovery?
Implementation requires curve-fitting expertise to apply exponential recovery models to time-series fluorescence data, enabling derivation of halftime and mobile fraction with goodness-of-fit assessment. Teams must also be capable of background correction, normalization to prebleach averages, and ROI-based intensity measurements using image analysis software. These analytical steps ensure that raw fluorescence traces are converted into comparable, quantitative metrics for decision-making in target validation and screening cascades.
Chapters in this video
0:04
Title
2:10
Cell Treatments and Laser Setup
3:44
Image Acquisition Setup and Collection
5:54
Data Analysis
8:08
Data Analysis in a Spreadsheet Program
10:16
Results: Fluorescence Recovery After Photobleaching of Yellow Fluorescent Protein Tagged p62 in Aggresome-like Induced Structures
11:20
Conclusion
